Correlation of preoperative combined positron emission tomography/computed tomograpy with surgical and histopathological findings for patients with endometrial cancer

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12609000402246

Acronym

None

Enrollment

Registered

2009-06-02

Start date

2009-04-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Prospective study to be conducted at Monash Medical Centre Moorabbin Melbourne Victoria. The aim is to determine whether Positron Emission Tomography combined with computed tomography (PET/CT) is able to predict the stage and spread of uterine (Endometrial) Cancer when performed preoperatively. A further aim is to determine whether its use is beneficial in guiding further treatment of the patient, With our hypothesis being that PET/CT is useful in ensuring appropriate management of the woman with uterine cancer

Interventions

preoperative combined positron emission tomography/computed tomograpy (PET/CT) This involves the patient undergoing a combined imaging technique: the patient is required to lie on their back in a PET/CT machine for approximately 40-60 minutes following administration of intravenous contrast agent as is normally given with routine CT, and injection of radioactive marker fluoro-2-deoxyglucose (FDG)

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Diagnosis

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Healthy volunteers

Inclusion criteria

All women presenting to Southern Health with diagnosis of endometrial cancer

Exclusion criteria

Previous surgery for endometrial cancer other cancers Not for surgical intervention

Outcome results